News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,520 Results
Type
Article (39739)
Company Profile (306)
Press Release (649475)
Section
Business (204866)
Career Advice (2005)
Deals (35482)
Drug Delivery (88)
Drug Development (81125)
Employer Resources (168)
FDA (16132)
Job Trends (14870)
News (346042)
Policy (32572)
Tag
Academia (2562)
Alliances (49479)
Alzheimer's disease (1241)
Approvals (16066)
Artificial intelligence (134)
Bankruptcy (354)
Best Places to Work (11574)
Biotechnology (217)
Breast cancer (131)
Cancer (1122)
Cardiovascular disease (102)
Career advice (1673)
Cell therapy (240)
Clinical research (64492)
Collaboration (401)
Compensation (202)
COVID-19 (2570)
C-suite (97)
Data (1150)
Diabetes (155)
Diagnostics (6168)
Earnings (84965)
Employer resources (146)
Events (110184)
Executive appointments (318)
FDA (16686)
Funding (363)
Gene therapy (179)
GLP-1 (584)
Government (4343)
Healthcare (18724)
Infectious disease (2655)
Inflammatory bowel disease (110)
Interviews (309)
IPO (16341)
Job creations (3660)
Job search strategy (1429)
Layoffs (418)
Legal (7890)
Lung cancer (172)
Manufacturing (179)
Medical device (13198)
Medtech (13203)
Mergers & acquisitions (19226)
Metabolic disorders (408)
Neuroscience (1524)
NextGen Class of 2024 (6540)
Non-profit (4483)
Northern California (1508)
Obesity (234)
Opinion (184)
Patents (105)
People (56640)
Phase I (20057)
Phase II (28410)
Phase III (21161)
Pipeline (466)
Postmarket research (2560)
Preclinical (8555)
Radiopharmaceuticals (236)
Rare diseases (224)
Real estate (5937)
Regulatory (21620)
Research institute (2330)
Resumes & cover letters (350)
Southern California (1325)
Startups (3617)
United States (13775)
Vaccines (556)
Weight loss (170)
Date
Today (122)
Last 7 days (603)
Last 30 days (3704)
Last 365 days (35951)
2024 (33177)
2023 (40202)
2022 (51322)
2021 (55878)
2020 (54218)
2019 (46705)
2018 (35158)
2017 (32254)
2016 (31678)
2015 (37742)
2014 (31506)
2013 (26538)
2012 (28808)
2011 (29457)
2010 (27547)
Location
Africa (717)
Arizona (193)
Asia (37412)
Australia (6125)
California (3407)
Canada (1312)
China (256)
Colorado (151)
Connecticut (155)
Europe (80215)
Florida (471)
Georgia (121)
Illinois (350)
Indiana (199)
Kansas (97)
Maryland (586)
Massachusetts (2662)
Michigan (159)
Minnesota (276)
New Jersey (977)
New York (980)
North Carolina (710)
Northern California (1508)
Ohio (141)
Pennsylvania (858)
South America (1096)
Southern California (1325)
Texas (489)
Utah (91)
Washington State (368)
689,520 Results for "replicate bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
Replicate Bioscience will be participating in the following upcoming investor meetings.
March 1, 2024
·
2 min read
Drug Development
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Replicate Bioscience presented new preclinical data and will share interim clinical trial results from an ongoing Phase 1 study at the American Society of Gene & Cell Therapy Annual Meeting, May 7-11 in Baltimore, Maryland.
May 11, 2024
·
4 min read
Biotech Beach
Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced acceptance of two oral presentations at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 7-11 in Baltimore, Maryland.
April 22, 2024
·
2 min read
Drug Development
Replicate Bioscience Announces Positive Initial Clinical Results for its Next Generation srRNA Technology
Replicate Bioscience today shared positive results from the Phase 1 trial of RBI-4000, its srRNA-based rabies vaccine.
February 14, 2024
·
4 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Press Releases
Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering
November 22, 2024
·
5 min read
Biotech Beach
Replicate Bioscience to Present Progress on Two srRNA Oncology Programs at Society for Immunotherapy of Cancer 2023 Meeting
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced a poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) 2023 38th Annual Meeting November 3-5, 2023 in San Diego, CA.
October 31, 2023
·
3 min read
Business
Replicate Bioscience Appoints Rachael Lester as Chief Business Officer
Replicate Bioscience announced today that it has appointed Rachael Lester as its Chief Business Officer.
July 10, 2023
·
3 min read
Press Releases
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
November 11, 2024
·
7 min read
1 of 68,952
Next
